SCCA’s Dr. Petros Grivas spoke on phase III JAVELIN Bladder 100 Trial Fred Hutch Patient Care 4:19 4 years ago 324 Далее Скачать
JAVELIN Bladder 100: duration of treatment-free interval VJOncology 3:13 3 years ago 137 Далее Скачать
Long term outcomes in JAVELIN Bladder 100: avelumab in urothelial carcinoma VJOncology 2:04 5 months ago 84 Далее Скачать
Researcher comment: The JAVELIN Bladder 100 trial | Thomas Powles Medicine Matters oncology 6:20 4 years ago 424 Далее Скачать
JAVELIN Bladder 100 trial: Biomarkers for maintenance avelumab in metastatic urothelial cancer Medicine Matters oncology 3:57 4 years ago 317 Далее Скачать
CLL highlights from ASH: the Phase III AMPLIFY trial VJHemOnc – Video Journal of Hematology & HemOnc 0:47 2 days ago 152 Далее Скачать
Expert comment: The JAVELIN Bladder 100 study | Elizabeth Plimack Medicine Matters oncology 3:52 4 years ago 86 Далее Скачать
Matthew Galsky, MD, shares the design and outcomes of the Javelin Bladder 100 study OBRoncology 2:12 4 years ago 66 Далее Скачать
Robert Dreicer, MD, describes the results of the Javelin-100 Bladder cancer trial OBRoncology 2:05 4 years ago 52 Далее Скачать
Rana McKay, MD, shares the design and outcomes of the Javelin Bladder 100 study OBRoncology 3:53 4 years ago 41 Далее Скачать
Dr. Konstantinopoulos on the Phase III Results of the JAVELIN 200 Trial in Ovarian Cancer OncLive 2:04 5 years ago 123 Далее Скачать
The JAVELIN 100 study: a trial to improve lung cancer treatment VJOncology 1:18 7 years ago 103 Далее Скачать
Petros Grivas, MD, PhD, offers perspective on the JAVELIN Bladder 100 trial updated at ESMO 2020 OBRoncology 1:33 4 years ago 31 Далее Скачать
